PTPRB and neoplasm: AKB-9778 moderately reduced the level of junctional VE-cadherin in 4E2-treated GBM vessels (Fig. 8g), suggesting that VE-PTP inhibition destabilizes endothelial junctions in normalized tumor vessels via VEGFR2 signaling.